{"id":522,"date":"2015-11-09T17:46:39","date_gmt":"2015-11-10T01:46:39","guid":{"rendered":"https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/"},"modified":"2024-11-07T16:20:01","modified_gmt":"2024-11-08T00:20:01","slug":"qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute","status":"publish","type":"post","link":"https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/","title":{"rendered":"Advancing Alzheimer\u2019s treatment options through collaboration"},"content":{"rendered":"\n \n \n\n\n\n\n\n\n\n
\n\n \n
\n \n
\n\n \n Press Release<\/span>\n\n\n\n<\/div>\n \n \n
\n\n \n

Advancing Alzheimer\u2019s treatment options through collaboration<\/h1>\n\n\n<\/div>\n \n \n
\n Hope Hamashige<\/span>\n \n November 09, 2015<\/span>\n <\/div>\n \n \n
\n\n \n
<\/path><\/svg><\/span><\/a><\/path><\/svg><\/span><\/a><\/path><\/svg><\/span><\/a><\/path><\/path><\/path><\/svg><\/span><\/a><\/path><\/svg><\/span><\/a><\/path><\/path><\/g><\/svg><\/span><\/a><\/svg><\/span><\/a><\/div>
<\/div><\/div>\n\n\n<\/div>\n \n <\/div>\n\n \n
\n\n \n \n \n
\n \n \n \n \n \n\n \n
Paul Aisen, MD, the founding director of the USC Alzheimer\u2019s Therapeutic Research Institute \/ Photo by Steve Cohn<\/figcaption>\n <\/figure>\n \n \n \n\n<\/div>\n \n\n <\/div><\/div>\n\r\n\r\n\n\n \n \n\n\n\n\n\n\n\n
\n\n \n
\n \n
\n\n \n

Paul Aisen, MD, the founding director of the USC Alzheimer\u2019s Therapeutic Research Institute<\/a>, is the newest member of the Keck School of Medicine of USC whose focus is Alzheimer\u2019s disease research. He recently spoke with us and answered a few questions about joining the Keck School and the progress of Alzheimer\u2019s disease research over the last 25 years.<\/p>\n

What excites you about joining the faculty at the Keck School of Medicine of USC?<\/h3>\n

I think Keck is the perfect home for my research group. We have enjoyed terrific support at all levels, allowing us to get our studies running in record time. And the academic environment is likewise terrific, as we build collaborations with outstanding leaders in Alzheimer\u2019s disease research, including Arthur Toga, Paul Thompson and Helena Chui.<\/p>\n

There is already a significant amount of Alzheimer’s disease-related research going on at Keck Medicine through the Alzheimer\u2019s Disease Research Center, USC Stevens Institute of Neuroimaging and Neuroinformatics and the Zilkha Neurogenetic Institute. How do you think the Alzheimer\u2019s Therapeutic Research Institute (ATRI) fits into that landscape?<\/h3>\n

ATRI\u2019s mission is to accelerate the development of effective treatments for Alzheimer\u2019s disease. We work on new methods (trial designs, outcome measures, analytical approaches), and design and implement multicenter trials. We look forward to collaboration with all of the research groups at the Keck School \u2014 all will contribute to our therapeutic studies.<\/p>\n

Take us back to the early days of your career when you decided to pursue research on Alzheimer\u2019s disease. What was like to be involved in Alzheimer\u2019s research then?<\/h3>\n

I think I was very fortunate to enter academic medicine just as the field of Alzheimer\u2019s therapeutic research was beginning. I had the opportunity to participate in the earliest studies, contributing to the development of the first drugs to be approved for the disease. Over the past 25 years, I have worked with remarkable investigators around the world on setting the stage for a new generation of therapies that we hope will bring this terrible disease under control. I don\u2019t think there is any more important or more exciting work in medicine.<\/p>\n

What changes have been most beneficial to advancing research?<\/h3>\n

The important advances are too many to name. But let me focus on one area: PET imaging. There are two primary abnormalities in the Alzheimer\u2019s disease brain: plaques, made of aggregated protein called amyloid, and tangles, deposits within brain cells made up of a protein called tau. For the past 10 years, we have been able to study the accumulation of amyloid plaques in the brain using PET scans. This changed our entire perspective on the disease, and revolutionized drug development. We now know that amyloid, the root cause of the disease, accumulates 15 years before the onset of symptoms of Alzheimer\u2019s disease. So we are now conducting our anti-amyloid trials during this asymptomatic phase when removal of amyloid is likely to be very effective. For the past two years, we have been able to visualize tangles as well, with a different type of PET scanning. With these two neuroimaging tools, we can analyze the course of the disease as never before, allowing accurate diagnosis very, very early, and enabling the accurate tracking of disease progression.<\/p>\n

You have been quoted recently saying that you think there is reason for optimism for patients with Alzheimer\u2019s disease. What do you see on the horizon that gives you hope?<\/h3>\n

With our new neuroimaging tools, and very promising therapeutic agents, I am confident that we will have effective treatments within the coming years. Ultimately, I believe we will be able to screen people in mid-life for evidence of amyloid dysregulation, so that we can administer treatments to prevent the accumulation of amyloid in brain, just as we treat elevated cholesterol to prevent the accumulation of plaques in arteries. We will be able to change the course of the most feared disease of aging.<\/p>\n\n\n\n<\/div>\n <\/div>\n\n\n <\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":36,"featured_media":523,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[38,489,234,20,103],"class_list":["post-522","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release","tag-administrative","tag-alzheimers-disease","tag-department-of-neurology","tag-research","tag-alzheimers-therapeutic-research-institute"],"acf":[],"yoast_head":"\nAdvancing Alzheimer\u2019s treatment options through collaboration<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Advancing Alzheimer\u2019s treatment options through collaboration\" \/>\n<meta property=\"og:url\" content=\"https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/\" \/>\n<meta property=\"og:site_name\" content=\"Newsroom\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/KECKschoolUSC\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-11-10T01:46:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-08T00:20:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2023\/11\/Paul-Aisen.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"447\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00a0Hope Hamashige\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@KeckSchool_USC\" \/>\n<meta name=\"twitter:site\" content=\"@KeckSchool_USC\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\\\/\"},\"author\":{\"name\":\"\u00a0Hope Hamashige\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#\\\/schema\\\/person\\\/6c41418a8885c90eeeb9123c6f352fcb\"},\"headline\":\"Advancing Alzheimer\u2019s treatment options through collaboration\",\"datePublished\":\"2015-11-10T01:46:39+00:00\",\"dateModified\":\"2024-11-08T00:20:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\\\/\"},\"wordCount\":7,\"publisher\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/68\\\/2023\\\/11\\\/Paul-Aisen.jpg\",\"keywords\":[\"Administrative\",\"Alzheimer\u2019s Disease\",\"Department of Neurology\",\"Research\",\"USC Epstein Family Alzheimer\u2019s Therapeutic Research Institute\"],\"articleSection\":[\"Press Release\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\\\/\",\"url\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\\\/\",\"name\":\"Advancing Alzheimer\u2019s treatment options through collaboration\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/68\\\/2023\\\/11\\\/Paul-Aisen.jpg\",\"datePublished\":\"2015-11-10T01:46:39+00:00\",\"dateModified\":\"2024-11-08T00:20:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/keck.usc.edu\\\/news\\\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\\\/#primaryimage\",\"url\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/68\\\/2023\\\/11\\\/Paul-Aisen.jpg\",\"contentUrl\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/68\\\/2023\\\/11\\\/Paul-Aisen.jpg\",\"width\":600,\"height\":447,\"caption\":\"Paul Aisen, MD, the founding director of the USC Alzheimer\u2019s Therapeutic Research Institute\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Advancing Alzheimer\u2019s treatment options through collaboration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#website\",\"url\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/\",\"name\":\"Newsroom\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#organization\",\"name\":\"Keck School of Medicine of USC\",\"alternateName\":\"Keck School of Medicine\",\"url\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/68\\\/2023\\\/11\\\/keck-school-of-medicine-logo-696-square.jpg\",\"contentUrl\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/wp-content\\\/uploads\\\/sites\\\/68\\\/2023\\\/11\\\/keck-school-of-medicine-logo-696-square.jpg\",\"width\":696,\"height\":696,\"caption\":\"Keck School of Medicine of USC\"},\"image\":{\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/KECKschoolUSC\\\/\",\"https:\\\/\\\/x.com\\\/KeckSchool_USC\",\"https:\\\/\\\/www.linkedin.com\\\/school\\\/keckschoolusc\\\/\",\"https:\\\/\\\/www.instagram.com\\\/KeckSchoolUSC\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCpL1E1W5ZTfkc5iihwLSFEA\",\"https:\\\/\\\/www.tiktok.com\\\/@keckschoolusc\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/#\\\/schema\\\/person\\\/6c41418a8885c90eeeb9123c6f352fcb\",\"name\":\"\u00a0Hope Hamashige\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e2f58b0896f55ccde5615b6dca7c541b7b9a1ab172f3aa3e70fe02e16c71a67b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e2f58b0896f55ccde5615b6dca7c541b7b9a1ab172f3aa3e70fe02e16c71a67b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e2f58b0896f55ccde5615b6dca7c541b7b9a1ab172f3aa3e70fe02e16c71a67b?s=96&d=mm&r=g\",\"caption\":\"\u00a0Hope Hamashige\"},\"url\":\"https:\\\/\\\/keck.usc.edu\\\/news\\\/author\\\/hope_hamashige\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Advancing Alzheimer\u2019s treatment options through collaboration","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/","og_locale":"en_US","og_type":"article","og_title":"Advancing Alzheimer\u2019s treatment options through collaboration","og_url":"https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/","og_site_name":"Newsroom","article_publisher":"https:\/\/www.facebook.com\/KECKschoolUSC\/","article_published_time":"2015-11-10T01:46:39+00:00","article_modified_time":"2024-11-08T00:20:01+00:00","og_image":[{"width":600,"height":447,"url":"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2023\/11\/Paul-Aisen.jpg","type":"image\/jpeg"}],"author":"\u00a0Hope Hamashige","twitter_card":"summary_large_image","twitter_creator":"@KeckSchool_USC","twitter_site":"@KeckSchool_USC","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/#article","isPartOf":{"@id":"https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/"},"author":{"name":"\u00a0Hope Hamashige","@id":"https:\/\/keck.usc.edu\/news\/#\/schema\/person\/6c41418a8885c90eeeb9123c6f352fcb"},"headline":"Advancing Alzheimer\u2019s treatment options through collaboration","datePublished":"2015-11-10T01:46:39+00:00","dateModified":"2024-11-08T00:20:01+00:00","mainEntityOfPage":{"@id":"https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/"},"wordCount":7,"publisher":{"@id":"https:\/\/keck.usc.edu\/news\/#organization"},"image":{"@id":"https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/#primaryimage"},"thumbnailUrl":"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2023\/11\/Paul-Aisen.jpg","keywords":["Administrative","Alzheimer\u2019s Disease","Department of Neurology","Research","USC Epstein Family Alzheimer\u2019s Therapeutic Research Institute"],"articleSection":["Press Release"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/","url":"https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/","name":"Advancing Alzheimer\u2019s treatment options through collaboration","isPartOf":{"@id":"https:\/\/keck.usc.edu\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/#primaryimage"},"image":{"@id":"https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/#primaryimage"},"thumbnailUrl":"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2023\/11\/Paul-Aisen.jpg","datePublished":"2015-11-10T01:46:39+00:00","dateModified":"2024-11-08T00:20:01+00:00","breadcrumb":{"@id":"https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/#primaryimage","url":"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2023\/11\/Paul-Aisen.jpg","contentUrl":"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2023\/11\/Paul-Aisen.jpg","width":600,"height":447,"caption":"Paul Aisen, MD, the founding director of the USC Alzheimer\u2019s Therapeutic Research Institute"},{"@type":"BreadcrumbList","@id":"https:\/\/keck.usc.edu\/news\/qa-paul-aisen-founding-director-of-the-usc-alzheimers-therapeutic-research-institute\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/keck.usc.edu\/news\/"},{"@type":"ListItem","position":2,"name":"Advancing Alzheimer\u2019s treatment options through collaboration"}]},{"@type":"WebSite","@id":"https:\/\/keck.usc.edu\/news\/#website","url":"https:\/\/keck.usc.edu\/news\/","name":"Newsroom","description":"","publisher":{"@id":"https:\/\/keck.usc.edu\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/keck.usc.edu\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/keck.usc.edu\/news\/#organization","name":"Keck School of Medicine of USC","alternateName":"Keck School of Medicine","url":"https:\/\/keck.usc.edu\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/keck.usc.edu\/news\/#\/schema\/logo\/image\/","url":"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2023\/11\/keck-school-of-medicine-logo-696-square.jpg","contentUrl":"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2023\/11\/keck-school-of-medicine-logo-696-square.jpg","width":696,"height":696,"caption":"Keck School of Medicine of USC"},"image":{"@id":"https:\/\/keck.usc.edu\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/KECKschoolUSC\/","https:\/\/x.com\/KeckSchool_USC","https:\/\/www.linkedin.com\/school\/keckschoolusc\/","https:\/\/www.instagram.com\/KeckSchoolUSC\/","https:\/\/www.youtube.com\/channel\/UCpL1E1W5ZTfkc5iihwLSFEA","https:\/\/www.tiktok.com\/@keckschoolusc"]},{"@type":"Person","@id":"https:\/\/keck.usc.edu\/news\/#\/schema\/person\/6c41418a8885c90eeeb9123c6f352fcb","name":"\u00a0Hope Hamashige","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e2f58b0896f55ccde5615b6dca7c541b7b9a1ab172f3aa3e70fe02e16c71a67b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e2f58b0896f55ccde5615b6dca7c541b7b9a1ab172f3aa3e70fe02e16c71a67b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e2f58b0896f55ccde5615b6dca7c541b7b9a1ab172f3aa3e70fe02e16c71a67b?s=96&d=mm&r=g","caption":"\u00a0Hope Hamashige"},"url":"https:\/\/keck.usc.edu\/news\/author\/hope_hamashige\/"}]}},"author_meta":{"display_name":"\u00a0Hope Hamashige","author_link":"https:\/\/keck.usc.edu\/news\/author\/hope_hamashige\/"},"featured_img":"https:\/\/keck.usc.edu\/news\/wp-content\/uploads\/sites\/68\/2023\/11\/Paul-Aisen-300x224.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/keck.usc.edu\/news\/category\/press-release\/\" class=\"advgb-post-tax-term\">Press Release<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Press Release<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/keck.usc.edu\/news\/category\/press-release\/\" class=\"advgb-post-tax-term\">Administrative<\/a>","<a href=\"https:\/\/keck.usc.edu\/news\/category\/press-release\/\" class=\"advgb-post-tax-term\">Alzheimer\u2019s Disease<\/a>","<a href=\"https:\/\/keck.usc.edu\/news\/category\/press-release\/\" class=\"advgb-post-tax-term\">Department of Neurology<\/a>","<a href=\"https:\/\/keck.usc.edu\/news\/category\/press-release\/\" class=\"advgb-post-tax-term\">Research<\/a>","<a href=\"https:\/\/keck.usc.edu\/news\/category\/press-release\/\" class=\"advgb-post-tax-term\">USC Epstein Family Alzheimer\u2019s Therapeutic Research Institute<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Administrative<\/span>","<span class=\"advgb-post-tax-term\">Alzheimer\u2019s Disease<\/span>","<span class=\"advgb-post-tax-term\">Department of Neurology<\/span>","<span class=\"advgb-post-tax-term\">Research<\/span>","<span class=\"advgb-post-tax-term\">USC Epstein Family Alzheimer\u2019s Therapeutic Research Institute<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 11 years ago","modified":"Updated 2 years ago"},"absolute_dates":{"created":"Posted on November 9, 2015","modified":"Updated on November 7, 2024"},"absolute_dates_time":{"created":"Posted on November 9, 2015 5:46 pm","modified":"Updated on November 7, 2024 4:20 pm"},"featured_img_caption":"Paul Aisen, MD, the founding director of the USC Alzheimer\u2019s Therapeutic Research Institute","series_order":"","_links":{"self":[{"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/posts\/522","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/comments?post=522"}],"version-history":[{"count":0,"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/posts\/522\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/media\/523"}],"wp:attachment":[{"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/media?parent=522"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/categories?post=522"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/keck.usc.edu\/news\/wp-json\/wp\/v2\/tags?post=522"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}